Neil Abdollahian's most recent trade in Boundless Bio Inc. was a trade of 82,051 Stock Option done . Disclosure was reported to the exchange on Aug. 19, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 82,051 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 82,051 | 82,051 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 54,871 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 54,871 | 54,871 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 36,852 | 36,852 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 36,852 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 23,191 | 23,191 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 23,191 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 19,948 | 0 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 19,948 | 19,948 | - | - | Stock Option | |
Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 23,191 | 23,191 | - | - | Stock Option | |
Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 3,500 | 58,940 (0%) | 0% | 0 | Common Stock | |
Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 05 Jan 2021 | 2,868 | 55,440 (0%) | 0% | 2.1 | 5,908 | Common Stock |
Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 05 Jan 2021 | 1,469 | 57,471 (0%) | 0% | 2.7 | 3,908 | Common Stock |
Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 115,000 | 115,000 | - | - | Employee Stock Option (right to buy) |